Anebulo Pharmaceuticals (ANEB) Cash & Current Investments (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted Cash & Current Investments of $9.04 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 39.7% from $15 million a year earlier and down 12.7% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Cash & Current Investments (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals' Cash & Current Investments came in at $11.63 million, up 275.8% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 30.9% (FY2020 to FY2025).
- In prior fiscal years, Anebulo Pharmaceuticals' Cash & Current Investments was $3.09 million in FY2024 (-72.5%), $11.25 million in FY2023 (-22.7%), $14.55 million in FY2022 (-27.2%) and $19.99 million in FY2021 (+560.7%).
- The fiscal Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since fiscal Q1 2025.
- On a year-over-year basis, Cash & Current Investments increased in four of the last eight quarters, with growth averaging 117.2%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was fiscal Q1 2026, with growth of 637.4%; the weakest was fiscal Q1 2025, with a decline of 83.5%.
- According to Business Quant data, Cash & Current Investments for the three prior fiscal quarters was $10.35 million (Q1 2026), $11.63 million (Q4 2025) and $13.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Anebulo Pharmaceuticals | 11.91 Mn | -32.39 Mn | - | 9.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.04 Mn |
| Sep 30, 2025 | 10.35 Mn |
| Jun 30, 2025 | 11.63 Mn |
| Mar 31, 2025 | 13.28 Mn |
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 3.09 Mn |
| Mar 31, 2024 | 5.15 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 8.52 Mn |
| Jun 30, 2023 | 11.25 Mn |
| Mar 31, 2023 | 14.16 Mn |
| Dec 31, 2022 | 16.36 Mn |
| Sep 30, 2022 | 19.21 Mn |
| Jun 30, 2022 | 14.55 Mn |
| Mar 31, 2022 | 16.55 Mn |
| Dec 31, 2021 | 18.01 Mn |
| Sep 30, 2021 | 19.21 Mn |
| Jun 30, 2021 | 19.99 Mn |
| Mar 31, 2021 | 3.31 Mn |
API Access
Anebulo Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();